Literature DB >> 14126057

ACTIONS OF MECAMYLAMINE, DIMECAMINE, PEMPIDINE AND THEIR TWO QUATERNARY METHO-SALTS AT THE NEUROMUSCULAR JUNCTION.

J G BLACKMAN, C RAY.   

Abstract

Mecamylamine, dimecamine and pempidine differed in neuromuscular-blocking activity on the isolated phrenic nerve-diaphragm preparation of the rat from the corresponding methiodides by a factor of less than two. It was concluded that the active component of each amine was the cation acting extracellularly. The finding that the neuromuscular-blocking activity of mecamylamine at pH 6.7 was similar to the activity at pH 7.7 did not refute this conclusion. Mecamylamine, dimecamine methiodide, dimecamine and pempidine, at concentrations insufficient to cause block, could increase the twitch response of the rat diaphragm; the ability to do this increased in the above order. With pempidine (the most active compound) this effect, on the isolated sartorius muscle of the frog, was a direct action. During steady partial block by each of the compounds, the responses to brief tetanic stimulation, to neostigmine and to an increase in calcium concentration were similar to those observed during block by tubocurarine. From indirect evidence, pempidine methiodide appeared both to enhance the release of acetylcholine from motor-nerve terminals and to cause postsynaptic block.

Entities:  

Keywords:  AMMONIUM COMPOUNDS; DIAPHRAGM; ELECTRIC STIMULATION; EXPERIMENTAL LAB STUDY; FROGS; GANGLIONIC BLOCKADERS; MECAMYLAMINE; NEUROMUSCULAR JUNCTION; PEMPIDINE; PHARMACOLOGY; PHRENIC NERVE; POULTRY; RATS

Mesh:

Substances:

Year:  1964        PMID: 14126057      PMCID: PMC1703911          DOI: 10.1111/j.1476-5381.1964.tb01543.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  17 in total

1.  Transmission at the giant motor synapses of the crayfish.

Authors:  E J FURSHPAN; D D POTTER
Journal:  J Physiol       Date:  1959-03-03       Impact factor: 5.182

2.  Mechanism of the increased acetylcholine sensitivity of skeletal muscle in low pH solutions.

Authors:  J DEL CASTILLO; T E NELSON; V SANCHEZ
Journal:  J Cell Comp Physiol       Date:  1962-02

3.  The isolated chick biventer cervicis nerve-muscle preparation.

Authors:  B L GINSBORG; J WARRINER
Journal:  Br J Pharmacol Chemother       Date:  1960-09

4.  The influence of mecamylamine on the action of certain other ganglionic blocking agents.

Authors:  J P PAYNE
Journal:  Br J Anaesth       Date:  1957-08       Impact factor: 9.166

5.  Mecamylamine and its mode of action.

Authors:  G BENNETT; C TYLER; E ZAIMIS
Journal:  Lancet       Date:  1957-08-03       Impact factor: 79.321

6.  The effects of mecamylamine in the cat as modified by the administration of carbon dioxide.

Authors:  J P PAYNE; G G ROWE
Journal:  Br J Pharmacol Chemother       Date:  1957-12

7.  Observations on the pharmacology of mecamylamine.

Authors:  M D MILNE; G G ROWE; K SOMERS; R C MUEHRCKE; M A CRAWFORD
Journal:  Clin Sci       Date:  1957-11       Impact factor: 6.124

8.  Adenosinetriphosphatase activity of brain.

Authors:  M B R GORE
Journal:  Biochem J       Date:  1951-11       Impact factor: 3.857

9.  Bicarbonate ion and striated muscle.

Authors:  R CREESE
Journal:  J Physiol       Date:  1949-12       Impact factor: 5.182

10.  Pharmacological properties of pempidine (1:2:2:6:6-pentamethylpiperidine), a new ganglion-blocking compound.

Authors:  S J CORNE; N D EDGE
Journal:  Br J Pharmacol Chemother       Date:  1958-09
View more
  3 in total

1.  Effects of quinuronium methylsulphate on voluntary muscle.

Authors:  P Eyre
Journal:  Br J Pharmacol Chemother       Date:  1968-03

2.  Pharmacology of pH effects on carotid body chemoreceptors in vitro.

Authors:  C Eyzaguirre; P Zapata
Journal:  J Physiol       Date:  1968-04       Impact factor: 5.182

3.  Modeling study of mecamylamine block of muscle type acetylcholine receptors.

Authors:  Konstantin Ostroumov; Asya Shaikhutdinova; Andrey Skorinkin
Journal:  Eur Biophys J       Date:  2007-10-16       Impact factor: 1.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.